What is B. Riley’s Estimate for Aspen Aerogels Q1 Earnings?

Aspen Aerogels, Inc. (NYSE:ASPN) – Investment analysts at B. Riley decreased their Q1 2025 earnings per share (EPS) estimates for shares of Aspen Aerogels in a report issued on Wednesday, February 19th. B. Riley analyst R. Pfingst now expects that the construction company will earn ($0.08) per share for the quarter, down from their prior forecast of $0.09. B. Riley currently has a “Buy” rating and a $22.00 target price on the stock. The consensus estimate for Aspen Aerogels’ current full-year earnings is $0.17 per share. B. Riley also issued estimates for Aspen Aerogels’ Q2 2025 earnings at $0.02 EPS and FY2025 earnings at $0.22 EPS.

Aspen Aerogels (NYSE:ASPN) last announced its quarterly earnings results on Wednesday, February 12th. The construction company reported $0.15 EPS for the quarter, beating the consensus estimate of $0.04 by $0.11. Aspen Aerogels had a return on equity of 7.49% and a net margin of 2.95%.

ASPN has been the subject of several other research reports. Canaccord Genuity Group lowered their price target on Aspen Aerogels from $20.00 to $15.00 and set a “buy” rating for the company in a research note on Friday, February 14th. Craig Hallum lowered their price target on Aspen Aerogels from $21.00 to $18.00 and set a “buy” rating for the company in a research note on Friday, February 14th. Barclays lowered their price target on Aspen Aerogels from $25.00 to $13.00 and set an “overweight” rating for the company in a research note on Wednesday. Seaport Res Ptn cut Aspen Aerogels from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, February 12th. Finally, Roth Mkm decreased their target price on Aspen Aerogels from $22.00 to $16.00 and set a “buy” rating for the company in a research report on Friday, February 14th. One analyst has rated the stock with a sell rating, one has given a hold rating and nine have given a buy rating to the company’s stock. Based on data from MarketBeat.com, Aspen Aerogels currently has an average rating of “Moderate Buy” and a consensus price target of $22.44.

Aspen Aerogels Trading Down 1.4 %

Shares of NYSE ASPN opened at $8.04 on Friday. The stock has a market cap of $659.27 million, a price-to-earnings ratio of 50.22 and a beta of 2.14. The business has a 50 day simple moving average of $11.65 and a 200 day simple moving average of $18.07. Aspen Aerogels has a 52 week low of $7.96 and a 52 week high of $33.15. The company has a debt-to-equity ratio of 0.27, a quick ratio of 2.48 and a current ratio of 2.93.

Institutional Inflows and Outflows

Large investors have recently modified their holdings of the business. Quest Partners LLC lifted its holdings in shares of Aspen Aerogels by 263.3% during the third quarter. Quest Partners LLC now owns 7,397 shares of the construction company’s stock worth $205,000 after buying an additional 5,361 shares during the last quarter. Sandia Investment Management LP acquired a new position in shares of Aspen Aerogels during the fourth quarter worth approximately $89,000. Pursue Wealth Partners LLC acquired a new position in shares of Aspen Aerogels during the third quarter worth approximately $222,000. Mesirow Financial Investment Management Inc. acquired a new position in shares of Aspen Aerogels during the third quarter worth approximately $252,000. Finally, Kovitz Investment Group Partners LLC acquired a new position in shares of Aspen Aerogels during the third quarter worth approximately $263,000. 97.64% of the stock is currently owned by institutional investors and hedge funds.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.